The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GLP-1 receptor agonist use and pancreatic cancer risk in patients with chronic pancreatitis.
 
Sarina Ailawadi
No Relationships to Disclose
 
Jennifer Murphy
No Relationships to Disclose
 
Michael Storandt
No Relationships to Disclose
 
Melissa Lumish
No Relationships to Disclose
 
Madison Conces
Consulting or Advisory Role - Guardant Health
Research Funding - Taiho Oncology (Inst)
Travel, Accommodations, Expenses - NCCN
 
Sakti Chakrabarti
Honoraria - BioMedical Insights; Cancer Expert Now; HalioDx; Histosonics; Natera; omnihealth Media; QED Therapeutics
Speakers' Bureau - Bristol Myers Squibb; Merck; Natera; Seagen; Takeda
Research Funding - Merck (Inst)
(OPTIONAL) Uncompensated Relationships - Binacea
 
Amr Mohamed
No Relationships to Disclose
 
David Bajor
Employment - University Hospitals Case Medical Center
Stock and Other Ownership Interests - Mirati Therapeutics
Honoraria - Agenus; Tempus
Consulting or Advisory Role - Guidepoint Global
Speakers' Bureau - Natera
Research Funding - Abbvie; Apexigen (Inst); Bristol-Myers Squibb/Celgene (Inst); Calithera Biosciences (Inst); GlaxoSmithKline (Inst); Rafael Pharmaceuticals (Inst); Seagen (Inst); Tesaro (Inst)
(OPTIONAL) Uncompensated Relationships - Alligator Bioscience
 
Amit Mahipal
Consulting or Advisory Role - AstraZeneca/MedImmune; Elevar Therapeutics; Guardant Health; Taiho Oncology
Speakers' Bureau - AstraZeneca; Exelixis; Taiho Oncology
Research Funding - Taiho Pharmaceutical